Intraperitoneal Carboplatin Prolongs PFS After Surgery in Ovarian Cancer
Intraperitoneal carboplatin can prolong progression-free survival, but not overall survival, in patients with ovarian cancer.
Intraperitoneal carboplatin can prolong progression-free survival, but not overall survival, in patients with ovarian cancer.
In a registry-based study, 5% of patients with gynecologic cancer died within 30 days of COVID-19 diagnosis.
The trend may be partially explained by increasing obesity rates, according to researchers.
Black and Hispanic patients are underrepresented in studies supporting NCCN guidelines for endometrial cancer.
Olaparib did improve the time to subsequent treatment and time to discontinuation or death.
The tool, called the “BLOODS score,” was developed to help identify patients who may benefit from preoperative planning and blood-saving techniques.
Data on overspending due to lenvatinib’s dose-specific packaging prompted the drug’s manufacturer to commit to changing its dose exchange program.
It may be time to revise US screening guidelines for cervical cancer in patients age 65 and older, according to researchers.
New data suggest that, contrary to popular belief, lesbian or bisexual women have a similar risk of HPV infection as heterosexual women.
The 4-year overall survival rate was similar with adjuvant chemotherapy and without it.